Infant formula comes under the microscope in China

Published On 16/07/2013 | By Kim de Kock | Consumer protection, Enforcement

In a recent post on our sister blog, China Law Insight, Susan Ning, Kate Peng, Huang Jing and Li Rui discuss the investigation initiated by the National Development and Reform Commission (NDRC) against several infant formula companies for the alleged violation of Article 14 of the Antimonopoly Law (AML).

This is the second investigation by the NDRC against resale price maintenance (RPM).  Earlier this year, as blogged about here, the NDRC investigated and fined China’s producers of premium liquor, Kweichow Moutai Co Ltd. and Wuliangye Group Co., Ltd. for RPM conduct.

Multiple infant formula companies are currently being investigated and media reports suggest that it was the high consumer price for infant formula that triggered the current NDRC investigation.

While, the outcomes of the investigation are uncertain, there is widespread speculation that the NDRC will impose large fines on the companies being investigated.  However, the AML does allow flexibility for how the regulator may approach this type of matter.

To read more about the various mechanisms outlined in the AML for purposes of assessing monopoly agreements in the investigation, see the article here.

Photo credit: nerissa’s ring / Foter / CC BY


Like this post? Share it... Email this to someone
Print this page
Share on LinkedIn
Share on Facebook
Tweet about this on Twitter

About The Author

is a Senior Associate in the Sydney office of King & Wood Mallesons where she specialises in anti-trust law, with a focus on mergers and acquisitions, access matters as well as general competition issues. Outside of the office, Kim has recently taken up surfing... but is probably not going to be appearing on the ASP tour any time soon.

Leave a Reply

Your email address will not be published.

sixteen + two =